Is this your brand? Sign in to claim ownership.
Sign in to claim this brandGuangzhou Hybribio Medicine Technology Ltd.
China·CN-MF-000027677
Last updated May 23, 2026
What Guangzhou Hybribio Medicine Technology Ltd. makes
The company develops in vitro diagnostic (IVD) kits for genetic and epigenetic testing, including real-time PCR and methylation analysis tools. These products detect gene polymorphisms and DNA methylation patterns linked to conditions such as hearing loss, pharmacogenetic responses, and metabolic disorders. Examples include kits for APOE and SLCO1B1 gene analysis, CYP enzyme polymorphism testing, and methylation assays for genes like SOX1-OT and HIST1H4F. Additional offerings include bisulfite conversion reagents for DNA methylation studies and HRM-based hearing loss susceptibility assays.
The portfolio comprises devices classified under Class A, IVD Annex II List B, and IVD General categories, reflecting their use in routine laboratory diagnostics and genetic screening. These products are registered in the EU’s eudamed database, ensuring compliance with European IVD regulations. The manufacturer is based in China.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Information
- Country
- China
- Address
- No.71, Fenghuang 3rd Road, Guangzhou, China
- Website
- hybribio.cn
- —
- —
- [email protected]
- Phone
- —
- PRRC Contact
- Zicong Zheng
- EUDAMED SRN
- CN-MF-000027677
- FDA FEI Number
- —
- DUNS Number
- —
Catalogue (16)
Related Companies
Authorised Representatives
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.